Our clinical study indicated that the expression levels of CD90 and miR-589-5p were significantly inversely correlated in the HCC clinical specimens, and CD90+ HCC samples or samples with decreased miR-589-5p expression showed more vascular invasion and reduced disease-free and overall survival. The gene discussed is THY1; the disease is hepatocellular carcinoma.